Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications. Article

Overview

authors

DeSancho, Maria Teresa
Pastores, Stephen M

publication date

June 27, 2012

published in

Evidence-based medicine Journal

Identity

Scopus Document Identifier

84873057606

Digital Object Identifier (DOI)

10.1136/eb-2012-100755

PubMed ID

22740355

Additional Document Info

has global citation frequency

1

volume

18

issue

1